|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bosutinib, Atc L01Ea04 (Obg) For The Period 01.10.2024 - 30.09.2026 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
17 Aug 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Allergen Extract From Exclusively Timothy Grass Pollen (Excl. Sut), Atc V01Aa02 For The Period 01.10.24-30.09.26 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
17 Aug 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bimekizumab, Atc L04Ac21 (Obo) For The Period 01.10.2024 - 30.09.2026 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
17 Aug 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
17 Aug 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Allergen Extract From Timothy Grass, Sweetgrass, Etc. (Excl. Sut), Atc V01Aa02 For The Period 01.10.24-30.09.26 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
17 Aug 2024 |
|
Summary:
Open House Drug Discount Agreements Treprostinil, Atc B01Ac21 Country:
Germany
Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
17 Aug 2024 |
|
Summary:
Open House Drug Discount Agreements Telmisartan, Atc C09Ca07 Country:
Germany
Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
17 Aug 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Raltegravir (Atc: J05Aj01). Country:
Germany
Notice Type:
Tender Notice Deadline:
28 Jul 2026 Posting Date:
17 Aug 2024 |
|
Summary:
0086 - Donauisar-Klinikum Deggendorf - Conversion Of The Central Pharmacy - Workbenches/Isolators Open Procedure Country:
Germany
Notice Type:
Tender Notice Deadline:
26 Aug 2024 Posting Date:
17 Aug 2024 |
|
Summary:
Open House Drug Rebate Agreements Febuxostat, Atc M04Aa03 Country:
Germany
Notice Type:
Tender Notice Deadline:
05 Aug 2026 Posting Date:
16 Aug 2024 |
Germany pharmaceuticals tenders and Bids
Find latest Germany pharmaceutical tenders and bids. Search for business opportunities and business intelligence for Germany pharmaceutical tenders, Germany pharmaceuticals bids contracts, pharma public procurement notices, Germany drugs tenders, Germany medicine tenders, Germany generic medicine tenders, pharmaceutical market reports, pharmaceutical market intelligence. Search for Germany tenders, bids, procurement, RFPs, RFQs, ICBs. Search for Germany pharmaceutical tenders online.
Healthcare and Medicine